[1]
V. M. Odyntsova and O. S. Bidnenko, “Excipients choice justification for the creation of Adamantane-1ammonium 2-((5-(adamantane-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetate tablets by the method of wet granulation (part 2)”, Current issues in pharmacy and medicine: science and practice, no. 2, Jun. 2017.